How one OD uses Oxervate for corneal healing
There is treatment hope for neurotrophic keratitis, a rare disease affecting the cornea.
Scott Schachter, OD, reviews Oxervate, the first FDA-approved treatment for neurotrophic keratitis to exhibit complete corneal healing.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Recent Videos
Related Content
